Affinivax Inc.
www.affinivax.comAffinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.
Read more
Affinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Associate Director , Financial Reporting and Technical Accounting
Email ****** @****.comPhone (***) ****-****Accounting Manager
Email ****** @****.comPhone (***) ****-****Senior Manufacturing Manager
Email ****** @****.comPhone (***) ****-****Manufacturing Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(79)
Reach decision makers at Affinivax Inc.
Free credits every month!
Affinivax Inc. FAQ
Newton, United States
Biotechnology Research
